Jingwen Song

Jingwen Song currently serves as a Scientist at Entrada Therapeutics, having previously held the position of Senior Scientist 2 and Senior Scientist 1 at Frontage Laboratories, Inc., where responsibilities included developing and validating methods for quantifying antisense oligonucleotides in various biological matrices to support IND pre-clinical and clinical studies. Prior to that, at Ohio University, Jingwen Song was a Graduate Student Research Assistant focused on the role of extracellular ATP in cancer metastasis and the identification of glucose transporter inhibitors affecting cancer cell growth. Jingwen also contributed as a Graduate Teaching Assistant, instructing various undergraduate laboratory courses, and conducted large-scale protein binding substrate screenings in Arabidopsis thaliana. Jingwen Song holds a PhD in Molecular and Cellular Biology from Ohio University and a Bachelor's degree in Life Science from Capital Normal University.